Zenas BioPharma, Inc. Common Stock
Symbol: ZBIO (NASDAQ)
20.15
▼ (-0.10%) -0.020
Company Description:
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Key Stats
- Today's Open: $20.14
- Today's High: $21.47
- Today's Low: $19.955
- Today's Volume: 227.29K
- Yesterday Close: $20.17
- Yesterday High: $20.92
- Yesterday Low: $19.68
- Yesterday Volume: 118.48K
- Last Min Volume: 202
- Last Min High: $20.184
- Last Min Low: $20.15
- Last Min VWAP: $20.17556
Company Profile
- Name: Zenas BioPharma, Inc. Common Stock
- Website: https://www.zenasbio.com
- Listed Date: 2024-09-13
- Location: WALTHAM, MA
- Market Status: Active
- CIK Number: 0001953926
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $833.36M
- Round Lot: 100
- Outstanding Shares: 42.11M
- Asset Type: CS
RECENT FILINGS FOR ZBIO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | SCHEDULE 13G/A | View |
| 2025-09-02 | 8-K | View |
| 2025-08-12 | S-8 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 8-K | View |
| 2025-06-06 | SCHEDULE 13D | View |
| 2025-06-04 | 8-K | View |
Latest News on ZBIO